sanofi-aventis and Columbia University Medical Center partnered to develop therapeutics targeting osteoblast-secreted peptide osteocalcin to treat diabetes under a three-year collaboration

Columbia University

U.S. / Academic

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

sanofi-aventis Group

France / Large-Cap Biopharma (>=$50 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced